Skip to content
GLP-1 Desk
Menu

Head-to-head dispatch

OrderlyMeds vs Sunlight

Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.

Dispatch #233
OrderlyMeds

OrderlyMeds is a telehealth provider selling compounded semaglutide and tirzepatide with no membership fees or hidden costs.

Marked down on: The $74 rate is a two-month starter plan billed as $149 up front, and it is open only to patients new to GLP-1 medication; the standing monthly rate is $149

FDAWarning letter issued to OrderlyMeds LLC dba OrderlyMeds in June 2026. See the FDA warning-letter database.

vs
Dispatch #23Desk pick
Sunlight

A LegitScript-certified compounded GLP-1 telehealth brand with flat, openly published pricing — semaglutide from $88/mo, tirzepatide from $157/mo — plus a separate peptide-therapy program (NAD+, and per the live site, sermorelin) under its own intake.

Marked down on: Injectable only for GLP-1 — no oral tablet route on semaglutide or tirzepatide, despite a generic "Injections and oral options available" line in one landing page's hero that matches nothing else on the site

Sunlight takes this head-to-head with the higher Desk Score, 84/100 (B) against 64/100 (C) for OrderlyMeds. OrderlyMeds still holds its ground where its strengths line up with yours.

Desk Score, dimension by dimension

Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.

OrderlyMeds

64/100

C

Overall

Sunlight

84/100

B

Price transparency

86
86

State access

24
96

Molecule range

66
76

Onboarding speed

74
84

Support responsiveness

78
78

Licensing & trust

51
86

The spec sheet

FieldOrderlyMedsSunlight
Semaglutide$74/mo (starting dose, 2-mo starter plan, new patients only, compounded)Starts at $88/mo (compounded, injection)
Tirzepatide$299/mo (compounded)Starts at $157/mo (compounded, injection)
CoverageCoverage not publishedAll 50 states (varies by provider licensure)
Brand-nameCompounded onlyCompounded only
Oral optionInjectable onlyInjectable only
Best forReaders who want a first GLP-1 course at a published starter rate, with the standing rate published beside it.Patients who want the lowest published entry price in the ranking and are comfortable with an injection-only compounded program, and don't need an oral or brand-name route.
Desk Score64/100C84/100B

The verdict

Desk pick — Sunlight

Sunlight takes this head-to-head with the higher Desk Score, 84/100 (B) against 64/100 (C) for OrderlyMeds. OrderlyMeds still holds its ground where its strengths line up with yours.

Choose OrderlyMeds if…

Readers who want a first GLP-1 course at a published starter rate, with the standing rate published beside it.

$74/mo (starting dose, 2-mo starter plan, new patients only, compounded) sema · $299/mo (compounded) tirz · Coverage not published

FDAWarning letter issued to OrderlyMeds LLC dba OrderlyMeds in June 2026. See the FDA warning-letter database.

Choose Sunlight if…

Patients who want the lowest published entry price in the ranking and are comfortable with an injection-only compounded program, and don't need an oral or brand-name route.

Starts at $88/mo (compounded, injection) sema · Starts at $157/mo (compounded, injection) tirz · All 50 states (varies by provider licensure)

Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we file on a provider reads the same either way. Read full breakdowns: OrderlyMeds · Sunlight.

Also here

CoreAge Rx tops every dispatch at 94/100

Whichever of these two you lean toward, the Desk's #1-rated provider outscores them both. The Desk's top dispatch: flat all-in pricing, both molecules, all 50 states — no teaser-rate traps.

More head-to-heads

Or see the full comparison hub and the complete ranking.

Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.